{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:03:56Z","timestamp":1788177836657,"version":"build-2803163510"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["126925"],"award-info":[{"award-number":["126925"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["121584"],"award-info":[{"award-number":["121584"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["124282"],"award-info":[{"award-number":["124282"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["129378"],"award-info":[{"award-number":["129378"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["117797"],"award-info":[{"award-number":["117797"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"crossref","award":["41071"],"award-info":[{"award-number":["41071"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Social Insurance Institution of Finland, Kuopio, Tampere","award":["9M048"],"award-info":[{"award-number":["9M048"]}]},{"name":"Social Insurance Institution of Finland, Kuopio, Tampere","award":["9N035"],"award-info":[{"award-number":["9N035"]}]},{"name":"Turku University Hospital Medical Funds"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.atherosclerosis.2012.06.062","type":"journal-article","created":{"date-parts":[[2012,7,18]],"date-time":"2012-07-18T14:53:28Z","timestamp":1342623208000},"page":"208-212","source":"Crossref","is-referenced-by-count":31,"title":["Plasminogen activator inhitor-1 associates with cardiovascular risk factors in healthy young adults in the Cardiovascular Risk in Young Finns Study"],"prefix":"10.1016","volume":"224","author":[{"given":"Juho R.H.","family":"Raiko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervi","family":"Oikonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Wendelin-Saarenhovi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niina","family":"Siitonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"K\u00e4h\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terho","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorma","family":"Viikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antti","family":"Jula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Britt-Marie","family":"Loo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risto","family":"Huupponen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Saarikoski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Juonala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olli T.","family":"Raitakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1080\/07853890500401234","article-title":"The metabolic syndrome and cardiovascular disease","volume":"38","author":"Bonora","year":"2006","journal-title":"Ann Med"},{"issue":"Suppl.","key":"10.1016\/j.atherosclerosis.2012.06.062_bib2","first-page":"S97","article-title":"Atherosclerosis: a cancer of the blood vessels?","volume":"116","author":"Ross","year":"2001","journal-title":"Am J Clin Pathol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib3","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1742-1241.2005.00379.x","article-title":"Pivotal role of plasminogen-activator inhibitor 1 in vascular disease","volume":"59","author":"Agirbasli","year":"2005","journal-title":"Int J Clin Pract"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2012.06.062_bib4","first-page":"969","article-title":"Regulation of plasminogen activator inhibitor type 1 gene expression by inflammatory mediators and statins","volume":"100","author":"Kruithof","year":"2008","journal-title":"Thromb Haemost"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1093\/oxfordjournals.eurheartj.a059384","article-title":"Evidence for increased levels of plasminogen activator inhibitor and tissue plasminogen activator in plasma of patients with angiographically verified coronary artery disease","volume":"10","author":"Olofsson","year":"1989","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib6","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2008.04.012","article-title":"Systemic and vascular markers of inflammation in relation to metabolic syndrome and insulin resistance in adults with elevated atherosclerosis risk","volume":"202","author":"Kressel","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2012.06.062_bib7","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J\u00a0Cell Physiol"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2012.06.062_bib8","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc Ther"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2012.06.062_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/sj.ijo.0802778","article-title":"Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1","volume":"28","author":"Skurk","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2012.06.062_bib10","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1161\/ATVBAHA.107.140046","article-title":"Vascular functions of the plasminogen activation system","volume":"27","author":"Fay","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"Suppl. 1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib11","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(01)00293-6","article-title":"Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001","volume":"103","author":"Huber","year":"2001","journal-title":"Thromb Res"},{"issue":"15","key":"10.1016\/j.atherosclerosis.2012.06.062_bib12","doi-asserted-by":"crossref","first-page":"6998","DOI":"10.1073\/pnas.89.15.6998","article-title":"Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries","volume":"89","author":"Schneiderman","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib13","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ijo.2009.204","article-title":"Adipocytokines and the risk of coronary heart disease in healthy middle aged men: the PRIME Study","volume":"34","author":"Luc","year":"2010","journal-title":"Int J Obes (Lond)"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2012.06.062_bib14","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000080884.27358.49","article-title":"Relationship of metabolic syndrome and fibrinolytic dysfunction to cardiovascular disease","volume":"108","author":"Anand","year":"2003","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2012.06.062_bib15","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCULATIONAHA.105.547836","article-title":"Comprehensive survey of common genetic variation at the plasminogen activator inhibitor-1 locus and relations to circulating plasminogen activator inhibitor-1 levels","volume":"112","author":"Kathiresan","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2012.06.062_bib16","article-title":"Follow-ups of the Cardiovascular Risk in Young Finns Study in 2001 and 2007: levels and 6-year changes in risk factors","author":"Raiko","year":"2009","journal-title":"J\u00a0Intern Med"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2012.06.062_bib17","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s001250100007","article-title":"Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss","volume":"44","author":"Mavri","year":"2001","journal-title":"Diabetologia"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2012.06.062_bib18","doi-asserted-by":"crossref","first-page":"461S","DOI":"10.1093\/ajcn\/83.2.461S","article-title":"Obesity and the role of adipose tissue in inflammation and metabolism","volume":"83","author":"Greenberg","year":"2006","journal-title":"Am J Clin Nutr"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2012.06.062_bib19","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0026-0495(99)90190-7","article-title":"Plasma plasminogen activator inhibitor-I is associated with plasma leptin irrespective of body mass index, body fat mass, and plasma insulin and metabolic parameters in premenopausal women","volume":"48","author":"De","year":"1999","journal-title":"Metabolism"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib20","doi-asserted-by":"crossref","first-page":"116","DOI":"10.4103\/2230-8210.91206","article-title":"Adipokines (adiponectin and plasminogen activator inhhibitor-1) in metabolic syndrome","volume":"16","author":"Garg","year":"2012","journal-title":"Ind J Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2012.06.062_bib21","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","article-title":"Adipose tissue as an endocrine organ","volume":"316","author":"Galic","year":"2010","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2012.06.062_bib22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.numecd.2009.01.011","article-title":"Plasma adiponectin levels in chronic kidney disease patients: relation with molecular inflammatory profile and metabolic status","volume":"20","author":"Norata","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2012.06.062_bib23","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1053\/ajkd.2001.29261","article-title":"Progression of diabetic nephropathy: role of plasma homocysteine and plasminogen activator inhibitor-1","volume":"38","author":"Hovind","year":"2001","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2012.06.062_bib24","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1073\/pnas.92.6.1851","article-title":"Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction","volume":"92","author":"Eriksson","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2012.06.062_bib25","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.ultrasmedbio.2010.05.003","article-title":"Tracking of noninvasive ultrasound measurements of subclinical atherosclerosis in adulthood: findings from the Cardiovascular Risk in Young Finns Study","volume":"36","author":"Raiko","year":"2010","journal-title":"Ultrasound Med Biol"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2012.06.062_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1055\/s-0037-1614999","article-title":"Fibrinogen, plasminogen activator inhibitor-1, and carotid intima-media wall thickness in the NHLBI Family Heart Study","volume":"79","author":"Folsom","year":"1998","journal-title":"Thromb Haemost"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012004388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915012004388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T02:09:29Z","timestamp":1561946969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915012004388"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0021915012004388"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.06.062","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}